Pfizer Inc. Chief Executive Officer Ian Read faced increasingly hostile questioning from U.K. lawmakers today over his takeover bid for AstraZeneca Plc.
Pfizer Inc. Chief Executive Officer Ian Read refused to be pinned down on his commitment to preserve jobs in the U.K. as skeptical lawmakers grilled him about the company’s unsolicited offer for AstraZeneca Plc.
Even in a high-stakes deal worth almost $120 billion, one that would create the world’s biggest drugmaker, the personal details matter.
"If we believe the value is still there and we believe, under our interpretation of these rules, there is still value, I see no reason why we would not be able to do an inversion."
- Ian Read on Oct 28, 2014